ITC LTD vs NATH BIO-GENES (I) LTD

A side-by-side comparison of ITC LTD (ITC) and NATH BIO-GENES (I) LTD (NATHBIOGEN) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, ITC LTD leads ITC vs NATHBIOGEN on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation13
  • Profitability40
  • Growth02
  • Size & financial health40
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

NATHBIOGEN takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

16.20
P/E ratio
6.99
5.01
P/B ratio
0.46
5.39%
Dividend yield
1.30%
₹16.51
EPS
₹21.91

Profitability

ITC takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

29.30%
Return on equity
5.47%
39.00%
Return on capital
7.00%
35.00%
EBITDA margin
12.00%
26.65%
Net margin
9.44%

Growth

NATHBIOGEN takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

3.60%
Revenue CAGR (3Y)
23.89%
2.57%
Profit CAGR (3Y)
6.27%

Size & financial health

ITC takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹3.34L Cr
Market cap
₹292 Cr
₹78,868 Cr
Revenue
₹445 Cr
₹21,018 Cr
Net profit
₹42 Cr
0.03
Debt / equity
0.18
ITC LTD
  • + ["Company is almost debt free.", "Stock is providing a good dividend yield of 5.45%.", "Company has a good return on equity (ROE) track record: 3 Years ROE 35.2%", "Company has been maintaining a healthy dividend payout of 74.5%"]
  • ["The company has delivered a poor sales growth of 9.87% over past five years."]
NATH BIO-GENES (I) LTD
  • + ["Stock is trading at 0.44 times its book value", "Debtor days have improved from 110 to 70.0 days."]
  • ["Tax rate seems low", "Company has a low return on equity of 5.93% over last 3 years.", "Earnings include an other income of Rs.15.2 Cr.", "Dividend payout has been low at 9.52% of profits over last 3 years"]
ITC LTD full analysis NATH BIO-GENES (I) LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

ITC vs NATHBIOGEN: Share Price, Valuation & Which to Buy | DocStoX